Latest Global Growth News

DataWorks Group has extended its $10 million Ontario self-exclusion contract to include advanced call centre services, adding $1.15 million in revenue and reinforcing its leadership in regulated gaming technology.

Kelly Partners Group Holdings posted a robust 24.5% revenue increase to $134.6 million in FY25, driven by strategic international expansions and acquisitions. The firm’s underlying profit after tax also rose 13%, underscoring its growing footprint across Australia, the US, and Ireland.

AGP Investment Management launches a secondary unit issue for the WCM Quality Global Growth Fund, offering investors a 1.25% loyalty bonus for holding units for 12 months. The fund also updates its distribution policy to target a 5% annual cash yield with quarterly payments.

Advanced Health Intelligence Ltd has secured up to AUD 5.5 million from Oakley Capital Partners to support its ASX reinstatement and global growth ambitions, while targeting an additional USD 6 million from strategic investors and unlocking AUD 3 million in R&D grants.

International Graphite Limited (ASX, IG6) has signed a cooperation agreement to develop a 3,000 t/y expandable graphite facility in Germany, advancing its global footprint alongside progress at its Collie micronising plant and Springdale project, supported by potential US Department of Defense funding.

EQ Resources delivered a robust Q4 FY2025 with strong tungsten output from its Spanish and Australian operations, bolstered by strategic capital raises and key plant enhancements.

Associate Global Partners Limited reported an 11% increase in funds under management to $1.397 billion for the June quarter 2025, alongside sustained positive operating cash flows and strong fund performance from its WCM strategies.

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

ImpediMed Limited reported a record quarter for its SOZO device sales with $6.3 million in contracts, supported by expanded US reimbursement coverage and new funding. Despite stable revenue, the company’s cost-cutting and strategic moves position it well for growth in FY26.

Knosys Limited sustains a robust $9.8 million Annual Recurring Revenue, extends its ANZ Bank contract, and accelerates AI-driven library technology development with promising early market feedback.

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.